clear

Bring Insights to Life

clear100px
Saama
Saama

Innovation and growth drive the life sciences industry. Yet increasing complexity, cost pressures, regulatory issues, and information overload are making innovation harder and harder to achieve.

colorful_DNA

What if you could manage, analyze, and turn massive volumes of data into valuable and actionable insights to sustain your innovation and maintain competitiveness?

What if you had insight into life science’s toughest challenges?

What if you could make better clinical decisions before and after product launch, ultimately bringing viable, safer products to market faster?

 

To achieve these goals, you need to unleash the power of your data across the entire drug and patient lifecycle, use real world evidence to your advantage, manage your aggregate spend, jumpstart the commercialization drug phase, better manage clinical operations, and much more.

Enter Saama.

Data Science at Its Most Insightful

Fluid Analytics℠ for Life Sciences

Saama can help you tackle the challenges you face as a life sciences company.

We have a successful track record of analyzing large volumes of data, understanding the complexity of unstructured and semi-structured data, and managing the speed of real-time data.  We offer comprehensive data and advanced analytics solutions to address your increasingly complex ecosystem of information. We enable you to:

  • Manage, analyze, and turn information into valuable and actionable insights
  • Leverage volumes of data and complex data types — image files, video, instrument data capture — into scientifically relevant insights
  • Improve operations management across the enterprise and an increasingly complex regulatory environment
  • Understand hidden trends and act before problems grow — reducing costs and increasing revenue

Data Science at Its Most Insightful

Ready Analytics for Life Sciences

Saama can help you tackle the challenges you face as a life sciences company.

We have a successful track record of analyzing large volumes of data, understanding the complexity of unstructured and semi-structured data, and managing the speed of real-time data.  We offer comprehensive data and advanced analytics solutions to address your increasingly complex ecosystem of information. We enable you to:

  • Manage, analyze, and turn information into valuable and actionable insights
  • Leverage volumes of data and complex data types – image files, video, instrument data capture – into scientifically relevant insights
  • Improve operations management across the enterprise and an increasingly complex regulatory environment
  • Understand hidden trends and act before problems grow — reducing costs and increasing revenue

Life Sciences Solution Areas

Clinical Development Analytics (CDA)

Identify High-performing Sites, Monitor Clinical Trial Progress

Our unique analytics assets and clinical data expertise offer the flexibility, speed, and ease of use to unleash the power of data, facilitate clinical trial decision making, predict milestone delays, monitor KPIs, mitigate risk, and ensure clinical operational efficiencies.

Real World Evidence Analytics (RWEA)

Always-On Analytics — Accelerate ROI, and Generate Clinical and Commercial Insights

Our unique analytics assets and health data expertise offer the flexibility, speed, and ease of use to unleash the power of data, prove clinical and economic value of products, increase market access, truncate product development timelines, and accelerate return on investment.

CLINICAL DEVELOPMENT ANALYTICS

REAL WORLD EVIDENCE ANALYTICS

Contract Management Analytics
Development Analytics
Clinical Operations/ Risk-Based Monitoring
Treatment Pathways
Population Characteristics
Clinical Development Feasibility
Market Focus
Natural History of Disease
Safety Signals
Contract Management Analytics

Contract Management Analytics

Saama's advanced analytics facilitate strategic Contract Research Organization (CRO) alliances and partnerships. Our Contract Management Analytics solution is driven by a unified work breakdown structure and bid grid.  We help your organization assess areas of high peak performances, such as incentivization and shared benefits, and low-performance, such as shared risk and improvement.

Development Analytics

Development Analytics

Saama provides study-to-patient level analytics in clinical trials for safe and effective evaluation of therapeutics during the drug development pipeline for pharmaceutical companies. This offers leverage for internal bio stats (medical affairs through pharmacovigilance or PV) or leverage for future study design: your organization can compare and contrast with your competitor landscape across therapeutic areas, indications, and regions.

Clinical Operations/ Risk-Based Monitoring

Clinical Operations and Risk-Based Monitoring

Saama's Clinical Operations and Risk-Based Monitoring analytics allows for monitoring of operations management, feasibility analysis, centralized monitoring, and also proactive risk mitigation of clinical trials. By forecasting trends such as milestone delays and relevant metrics, corrective actions can be taken with confidence.

Treatment Pathways

Treatment Pathways

This allows you to discern patient treatment switches for a target disease or cohort, and then visualize for insights of treatment outcomes. Treatment Pathways can help your organization define real world treatment patterns based on information from routinely collected health records. Understanding average ‘days on therapy’ and treatment switches your organization to prepare clinical development plans and understand the real areas of opportunity — everything from patient acquisition to satisfaction and retention.

Population Characteristics

Population Characteristics

Population Characteristics can help you understand incident rates and co-morbidities of a disease across a target population/cohort to optimize patient recruitment. With population monitoring, your company can develop knowledge around treatment discontinuation, lab result trends, and clinical outcomes.

Clinical Development Feasibility

Clinical Development Feasibility

Clinical Development Feasibility defines cohorts by inclusion/exclusion criteria and uncovers key areas for protocol design improvement, which leads to avoidance of costly amendments. In addition, it helps pinpoint principal investigators and institutions that are prime for enrolling the target cohort.

Market Focus

Market Focus

Market Focus allows you to better navigate patient journeys, leverage the information for trend isolation of affiliates, payers, and the provider landscape, and better assess high-performing accounts and drugs. This capability allows you to target pull-through opportunities and other areas for competitive marketing.

Nearly 85 percent of all prescription drugs today are reimbursed through a managed care plan. The Saama Managed Care solution helps drive planning, monitoring, and optimizing for key accounts and helps your account managers get integrated intelligence and actionable insights.

Natural History of Disease

Natural History of Disease

Our analytics offering here helps you map out the progression of disease from sub-clinical state to clinical diagnosis and prognosis with our Natural History of Disease capability. You can determine the key mix of medical history details to predict onset to outcome.

It uses longitudinal patient records to define incidence/prevalence rates of any recorded disease and forecasting for sub-population trends. These data mining techniques have guided clinical development plans for rare disease trial recruitment, enabling a focus on specific patient groups ultimately accelerating regulatory evidence generation.

Safety Signals

Safety Signals

Our Safety Signals capability accelerates active post-marketing signal detection, substantiation, and compliance reporting of adverse event drug pairs — all based on EHR, EMR, and SRS data. By driving cohort studies through a guided analytics interface, our services allow your researchers and physicians to understand signals related to adverse events across millions of patients.

CLINICAL DEV ANALYTICS

Contract Management Analytics
Development Analytics
Clinical Operations/ Risk-Based Monitoring
Contract Management Analytics

Contract Management Analytics

Saama advanced analytics facilitate strategic Contract Research Organization (CRO) alliances and partnerships. Our Contract Management Analytics solution is driven by  a unified work breakdown structure and bid grid.  We help your organization assess areas of high peak performances such as incentivization and shared benefits, and low-performance such as shared risk and improvement.

Development Analytics

Development Analytics

Saama provides study-to-patient level analytics in clinical trials for safe and effective evaluation of therapeutics during the drug development pipeline for pharmaceutical companies. This offers leverage for internal bio stats (medical affairs through pharmacovigilance or PV) or leverage for future study design: your organization can compare and contrast with your competitor landscape across therapeutic areas, indications, and regions.

Clinical Operations/ Risk-Based Monitoring

Clinical Operations and Risk-Based Monitoring

This includes operations management, feasibility analysis, centralized monitoring and proactive risk mitigation of clinical trials.

REAL WORLD ANALYTICS

Cohort Builder
Treatment Pathways
Population Characteristics
Clinical Development Feasibility
Market Focus
Natural History of Disease
Safety Signals
Cohort Builder

Cohort Builder

Saama Cohort Builder enables your organization to build sample populations of patient-based inclusion and exclusion criteria and perform further analysis using other RWA modules.

Treatment Pathways

Treatment Pathways

This allows you to discern patient treatment switches for a target disease or cohort, and then visualize for insights of treatment outcomes. Treatment Pathways can help your organization define real world treatment patterns based on information from routinely collected health records. Understanding average ‘days on therapy’ and treatment switches your organization to prepare clinical development plans and understand the real areas of opportunity — everything from patient acquisition to satisfaction, and retention.

Population Characteristics

Population Characteristics

Population Characteristics can help you understand incident rates and co-morbidities of a disease across a target population/cohort to optimize patient recruitments. With population monitoring, your life sciences firm can develop knowledge around treatment discontinuation, lab result trends, and clinical outcomes.

Clinical Development Feasibility

Clinical Development Feasibility

The Saama Clinical Development Feasibility defines cohorts by inclusion and exclusion criteria and uncovers key areas for protocol design improvement which leads to avoidance of costly amendments. In addition, it helps pinpoint principal investigators and institutions that are prime for enrolling the target cohort. 

Market Focus

Market Focus

This capability allows you to better navigate patient journeys, leverage the information for trend isolation of affiliates, payers, and the provider landscape — and better assess high-performing accounts and drugs. You can target pull-through opportunities and other areas for competitive marketing.

Nearly 85 percent of all prescription drugs today are reimbursed through a managed care plan. The Saama Managed Care solution helps drive planning, monitoring, and optimizing for key accounts and helps your account managers get integrated intelligence and actionable insights.

Natural History of Disease

Natural History of Disease

Our analytics offering here helps you map out the the  progression of disease from sub-clinical state to clinical diagnosis and prognosis with our Natural History of Disease capability. You can determine the key mix of medical history details to predict onset to outcome.

It uses longitudinal patient records to define incidence/prevalence rates of any recorded disease and forecasting for sub-population trends. These data mining techniques have guided clinical development plans for rare disease trial recruitment, enabling a focus on specific patient groups ultimately accelerating regulatory evidence generation.

Safety Signals

Safety Signals

Our Safety Signals capability accelerates active post-marketing signal detection, substantiation, and compliance reporting of adverse event drug pairs — all based on EHR, EMR, and SRS data. By driving cohort studies through a guided analytics interface, our services allow your researchers and physicians to understand signals related to adverse events across millions of patients.

Fluid Analytics℠ for Life Sciences

The Saama Fluid Analytics for Life Sciences is an industry-specific orchestration environment that integrates and aggregates structured and unstructured data.

Includes such features as:

  • Enterprise-wide data model
  • Extensible and flexible framework for easier customization
  • Predefined data mapping templates that interface with source systems to mitigate development efforts and accelerate implementation of a robust data warehouse.
  • Data architecture that maintains availability, reliability, scalability and data load strategies that follow best practices and ease ongoing data maintenance.
  • Advanced analytical data components to facilitate business intelligence strategy that enables you to quickly measure success and improve your  performance with highly rated performance metrics.

CASE STUDY

Less than 3 Months to Disease Insights

Challenge:

A large global pharmaceutical company wanted to leverage their Real World Evidence Analytics (RWEA) investments to gain new insights and analytics into disease portfolios. The problem? They weren’t able to quickly and easily query real world patient data — it required expert SAS programmers and months of time to get real insights.

Solution

Saama delivered a customized implementation of the Saama Treatment Pathway Analytics, which offered a comprehensive view of RWE data for oncology and respiratory diseases — from disease progression to classification of severity, treatment step-up and down, and hazard ratios for patient cohorts. The solution was delivered over a private cloud.

Results

While the oncology group began with five to eight users, it has since grown to nearly 100, and due to this success, the solution for the respiratory franchise has expanded to a larger audience as well.  Benefits included faster analytics insights (such as treatment information in minutes); simplified user interface for easy accessibility to information; and a consolidated view of patients RWEA data.

Latest Resources

Resources_Life_Sciences_Brochure_Hero

Saama for Life Sciences

Get the brochure

 

Resources_Life_Sciences_Case_Study_Hero1

An analytics platform for contract management

Get the case study

saama-rwe-global-pharma

Real World Evidence at a global pharmaceutical

Get the case study

RSS
EMAIL
Facebook
GOOGLE
https://www.saama.com/industries/life-sciences/">
LinkedIn
Twitter
YouTube